The Filings Report

Cognex Corp

CGNXNasdaqCIK 851205Technology / Electronic Components & Instrumentsfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$313M
+13.2% on Q3 FY2025
Net income
$85M
+380.2% on Q3 FY2025
Free cash flow
$104M
+20.6% on Q3 FY2025
Diluted EPS
$0.50
+400.0% on Q3 FY2025
Revenue, TTM
$1.1B
trailing four quarters
Net margin, TTM
21.5%
net income $242M
Free cash flow, TTM
$286M
$296M less $10M capex
Cash and equivalents
$695M
long-term debt —, Oct 4, 2026
Shares, 12-month change
+0.5%
168M shares, Oct 4, 2026
Buybacks, TTM
$130M
1.6% of market value
Dividends, TTM
$57M
0.7% of market value
Market value
$8.0B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended October 4, 2026, Cognex Corp reported revenue of $313M, +13.2% on Q3 FY2025, and net income of $85M (+380.2%). Operating margin was 32.2%. Free cash flow, operating cash flow less capital expenditures, was $104M ($106M less $3M). Diluted earnings per share were $0.50.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

CGNX daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $48.95 · H $49.49 · L $47.21 · C $47.78 · +0.59% on the dayOver the range: +20.84%, Nov 7, 2025 to Nov 6, 2026
$32$43$54$64$75Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 5, 2026.

Revenue and net incomeRevenueNet income
$0$100M$200M$300M$400MQ4'22, Revenue: $239MQ4'22, Net income: $55MQ4'22Q1'23, Revenue: $201MQ1'23, Net income: $26MQ1'23Q2'23, Revenue: $243MQ2'23, Net income: $57MQ2'23Q3'23, Revenue: $197MQ3'23, Net income: $19MQ3'23Q4'23, Revenue: $197MQ4'23, Net income: $11MQ4'23Q1'24, Revenue: $211MQ1'24, Net income: $12MQ1'24Q2'24, Revenue: $239MQ2'24, Net income: $36MQ2'24Q3'24, Revenue: $235MQ3'24, Net income: $30MQ3'24Q4'24, Revenue: $230MQ4'24, Net income: $28MQ4'24Q1'25, Revenue: $216MQ1'25, Net income: $24MQ1'25Q2'25, Revenue: $249MQ2'25, Net income: $41MQ2'25Q3'25, Revenue: $277MQ3'25, Net income: $18MQ3'25Q4'25, Revenue: $252MQ4'25, Net income: $33MQ4'25Q1'26, Revenue: $268MQ1'26, Net income: $52MQ1'26Q2'26, Revenue: $291MQ2'26, Net income: $73MQ2'26Q3'26, Revenue: $313MQ3'26, Net income: $85MQ3'26$0$100M$200M$300M$400MQ4'22, Revenue: $239MQ4'22, Net income: $55MQ4'22Q1'23, Revenue: $201MQ1'23, Net income: $26MQ1'23Q2'23, Revenue: $243MQ2'23, Net income: $57MQ2'23Q3'23, Revenue: $197MQ3'23, Net income: $19MQ3'23Q4'23, Revenue: $197MQ4'23, Net income: $11MQ4'23Q1'24, Revenue: $211MQ1'24, Net income: $12MQ1'24Q2'24, Revenue: $239MQ2'24, Net income: $36MQ2'24Q3'24, Revenue: $235MQ3'24, Net income: $30MQ3'24Q4'24, Revenue: $230MQ4'24, Net income: $28MQ4'24Q1'25, Revenue: $216MQ1'25, Net income: $24MQ1'25Q2'25, Revenue: $249MQ2'25, Net income: $41MQ2'25Q3'25, Revenue: $277MQ3'25, Net income: $18MQ3'25Q4'25, Revenue: $252MQ4'25, Net income: $33MQ4'25Q1'26, Revenue: $268MQ1'26, Net income: $52MQ1'26Q2'26, Revenue: $291MQ2'26, Net income: $73MQ2'26Q3'26, Revenue: $313MQ3'26, Net income: $85MQ3'26$0$100M$200M$300M$400MQ4'22, Revenue: $239MQ4'22, Net income: $55MQ1'23, Revenue: $201MQ1'23, Net income: $26MQ1'23Q2'23, Revenue: $243MQ2'23, Net income: $57MQ3'23, Revenue: $197MQ3'23, Net income: $19MQ3'23Q4'23, Revenue: $197MQ4'23, Net income: $11MQ1'24, Revenue: $211MQ1'24, Net income: $12MQ1'24Q2'24, Revenue: $239MQ2'24, Net income: $36MQ3'24, Revenue: $235MQ3'24, Net income: $30MQ3'24Q4'24, Revenue: $230MQ4'24, Net income: $28MQ1'25, Revenue: $216MQ1'25, Net income: $24MQ1'25Q2'25, Revenue: $249MQ2'25, Net income: $41MQ3'25, Revenue: $277MQ3'25, Net income: $18MQ3'25Q4'25, Revenue: $252MQ4'25, Net income: $33MQ1'26, Revenue: $268MQ1'26, Net income: $52MQ1'26Q2'26, Revenue: $291MQ2'26, Net income: $73MQ3'26, Revenue: $313MQ3'26, Net income: $85MQ3'26

Net income losses drawn in red.

Free cash flow
$0$50M$100M$150MQ4'22, Free cash flow: $62MQ4'22Q1'23, Free cash flow: $22MQ1'23Q2'23, Free cash flow: $25MQ2'23Q3'23, Free cash flow: $35MQ3'23Q4'23, Free cash flow: $7MQ4'23Q1'24, Free cash flow: $10MQ1'24Q2'24, Free cash flow: $23MQ2'24Q3'24, Free cash flow: $52MQ3'24Q4'24, Free cash flow: $49MQ4'24Q1'25, Free cash flow: $38MQ1'25Q2'25, Free cash flow: $40MQ2'25Q3'25, Free cash flow: $86MQ3'25Q4'25, Free cash flow: $72MQ4'25Q1'26, Free cash flow: $42MQ1'26Q2'26, Free cash flow: $68MQ2'26Q3'26, Free cash flow: $104MQ3'26$0$50M$100M$150MQ4'22, Free cash flow: $62MQ4'22Q1'23, Free cash flow: $22MQ1'23Q2'23, Free cash flow: $25MQ2'23Q3'23, Free cash flow: $35MQ3'23Q4'23, Free cash flow: $7MQ4'23Q1'24, Free cash flow: $10MQ1'24Q2'24, Free cash flow: $23MQ2'24Q3'24, Free cash flow: $52MQ3'24Q4'24, Free cash flow: $49MQ4'24Q1'25, Free cash flow: $38MQ1'25Q2'25, Free cash flow: $40MQ2'25Q3'25, Free cash flow: $86MQ3'25Q4'25, Free cash flow: $72MQ4'25Q1'26, Free cash flow: $42MQ1'26Q2'26, Free cash flow: $68MQ2'26Q3'26, Free cash flow: $104MQ3'26$0$50M$100M$150MQ4'22, Free cash flow: $62MQ1'23, Free cash flow: $22MQ1'23Q2'23, Free cash flow: $25MQ3'23, Free cash flow: $35MQ3'23Q4'23, Free cash flow: $7MQ1'24, Free cash flow: $10MQ1'24Q2'24, Free cash flow: $23MQ3'24, Free cash flow: $52MQ3'24Q4'24, Free cash flow: $49MQ1'25, Free cash flow: $38MQ1'25Q2'25, Free cash flow: $40MQ3'25, Free cash flow: $86MQ3'25Q4'25, Free cash flow: $72MQ1'26, Free cash flow: $42MQ1'26Q2'26, Free cash flow: $68MQ3'26, Free cash flow: $104MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $181MQ4'22Q1'23, Cash and equivalents: $164MQ1'23Q2'23, Cash and equivalents: $177MQ2'23Q3'23, Cash and equivalents: $396MQ3'23Q4'23, Cash and equivalents: $203MQ4'23Q1'24, Cash and equivalents: $139MQ1'24Q2'24, Cash and equivalents: $177MQ2'24Q3'24, Cash and equivalents: $197MQ3'24Q4'24, Cash and equivalents: $186MQ4'24Q1'25, Cash and equivalents: $144MQ1'25Q2'25, Cash and equivalents: $179MQ2'25Q3'25, Cash and equivalents: $246MQ3'25Q4'25, Cash and equivalents: $263MQ4'25Q1'26, Cash and equivalents: $237MQ1'26Q2'26, Cash and equivalents: $303MQ2'26Q3'26, Cash and equivalents: $695MQ3'26$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $181MQ4'22Q1'23, Cash and equivalents: $164MQ1'23Q2'23, Cash and equivalents: $177MQ2'23Q3'23, Cash and equivalents: $396MQ3'23Q4'23, Cash and equivalents: $203MQ4'23Q1'24, Cash and equivalents: $139MQ1'24Q2'24, Cash and equivalents: $177MQ2'24Q3'24, Cash and equivalents: $197MQ3'24Q4'24, Cash and equivalents: $186MQ4'24Q1'25, Cash and equivalents: $144MQ1'25Q2'25, Cash and equivalents: $179MQ2'25Q3'25, Cash and equivalents: $246MQ3'25Q4'25, Cash and equivalents: $263MQ4'25Q1'26, Cash and equivalents: $237MQ1'26Q2'26, Cash and equivalents: $303MQ2'26Q3'26, Cash and equivalents: $695MQ3'26$0$200M$400M$600M$800MQ4'22, Cash and equivalents: $181MQ1'23, Cash and equivalents: $164MQ1'23Q2'23, Cash and equivalents: $177MQ3'23, Cash and equivalents: $396MQ3'23Q4'23, Cash and equivalents: $203MQ1'24, Cash and equivalents: $139MQ1'24Q2'24, Cash and equivalents: $177MQ3'24, Cash and equivalents: $197MQ3'24Q4'24, Cash and equivalents: $186MQ1'25, Cash and equivalents: $144MQ1'25Q2'25, Cash and equivalents: $179MQ3'25, Cash and equivalents: $246MQ3'25Q4'25, Cash and equivalents: $263MQ1'26, Cash and equivalents: $237MQ1'26Q2'26, Cash and equivalents: $303MQ3'26, Cash and equivalents: $695MQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 5, 2026.

Cognex Corp income statement, quarterly
Millions of dollarsQ3 FY2026ended Oct 4, 2026filed Nov 5, 2026Q2 FY2026ended Jul 5, 2026filed Aug 6, 2026Q1 FY2026ended Apr 5, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 30, 2025Q2 FY2025ended Jun 29, 2025filed Jul 31, 2025Q1 FY2025ended Mar 30, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue313291268252277249216230+13.2%
Cost of revenue9285778690817272+2.3%
Gross profit222206191166187168144158+18.4%
Research and development3432373635333533−3.4%
Selling, general and administrative8788949594918494−7.9%
Operating income10186603558432631+74.5%
Other income (expense)00(2)50200−339.3%
Pretax income10389624463482836+64.3%
Income tax1817101145847−59.1%
Net income8573523318412428+380.2%
Diluted EPS ($)0.500.430.31—0.100.240.14—+400.0%
Diluted shares (millions)171170168—169169170——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 5, 2026.

Cognex Corp balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Oct 4, 2026filed Nov 5, 2026Q2 FY2026ended Jul 5, 2026filed Aug 6, 2026Q1 FY2026ended Apr 5, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 30, 2025Q2 FY2025ended Jun 29, 2025filed Jul 31, 2025Q1 FY2025ended Mar 30, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents695303237263246179144186+182.5%
Short-term investments1102597454495760−98.2%
Total current assets1,152850690697671626578613+71.7%
Total assets2,2762,1792,0062,0172,0032,0041,9331,993+13.7%
Total current liabilities229216189184169190184169+35.1%
Long-term debt—————————
Total liabilities555549527525513497487475+8.2%
Stockholders’ equity1,7211,6301,4791,4921,4901,5061,4461,518+15.6%
Shares outstanding (millions)168168166166168168168170—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 5, 2026.

Cognex Corp cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Oct 4, 2026filed Nov 5, 2026Q2 FY2026ended Jul 5, 2026filed Aug 6, 2026Q1 FY2026ended Apr 5, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 28, 2025filed Oct 30, 2025Q2 FY2025ended Jun 29, 2025filed Jul 31, 2025Q1 FY2025ended Mar 30, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow10669457587434151+21.6%
Capital expenditures32331232+81.7%
Free cash flow (CFO − capex)10468427286403849+20.6%
Depreciation and amortization—————————
Share repurchases06992524010243−100.0%
Dividends paid1414141413131414+6.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.

Income statement

Cognex Corp income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed Feb 11, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Aug 2, 2010FY2008ended Dec 31, 2008filed Aug 2, 2010
Revenue9949158381,0061,037811726806766530451426308324322291176243
Cost of revenue32928923628427720619020618713110394637978785668
Gross profit665626601722760605536600579398348332245245244213119174
Research and development13914013914113513111911699787056444241333136
Selling, general and administrative36437133931230926827426322116615714912412011810496113
Operating income16311513124631517114322125915412212877838576(13)25
Other income (expense)7110(1)010011000(1)(1)11
Pretax income18313113525131918716323526616212713278878776(10)35
Income tax682522353911(41)159018192111191715(6)5
Net income11410611321628017620421917714418712174687061(5)27
Diluted EPS ($)0.680.620.651.231.561.001.161.240.980.831.060.68*0.41*0.39*0.41*0.38*(0.03)*0.17*
Diluted shares (millions)169173173175180177175177180174176178*178*175*171*161*159*166*

Balance sheet

Cognex Corp balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed Feb 11, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Aug 2, 2010FY2008ended Dec 31, 2008filed Aug 2, 2010
Cash and equivalents26318620318118626917110810780525641453833120127
Short-term investments74601292191371032404272983412969018510514414856—
Total current assets697613679718640602607780630526444272332240285279249—
Total assets2,0171,9932,0181,9582,0041,8011,8861,2901,2881,039888822710628612533440—
Total current liabilities184169152188189132120911136654816150545439—
Long-term debt——————————————————
Total liabilities525475513520574539530154192766285——————
Stockholders’ equity1,4921,5181,5051,4381,4301,2621,3561,1351,096963832736644572553473394413
Shares outstanding (millions)166170172173174176173171174172*170*173*174*172*170*165*——

Cash flow statement

Cognex Corp cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 16, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 10, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed Feb 11, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Aug 2, 2010FY2008ended Dec 31, 2008filed Aug 2, 2010
Operating cash flow2461491132433142422532232241821281649510186761259
Capital expenditures9152320151322372913182110108656
Free cash flow (CFO − capex)2371349022429922923218619616911014386917870753
Depreciation and amortization———————————121111101011—
Share repurchases15167802041625162204124471266048010——93
Dividends paid55524946433913532292518006615101219

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$2M
5 sales by 1 insider; officers and directors $2M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$35M
42 sales by 9 insiders; officers and directors $35M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Aug 11, 2026Moschner MatthewCEO & President, Directoroption exercise1,600$56.44$90K20,846Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoropen-market sale1,600$65.36$105K19,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoroption exercise4,000$51.49$206K23,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoropen-market sale4,000$65.36$261K19,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoroption exercise4,000$40.71$163K23,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoropen-market sale4,000$63.62$254K19,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoroption exercise7,000$42.84$300K26,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoropen-market sale7,000$63.61$445K19,246Aug 12, 2026
Aug 11, 2026Moschner MatthewCEO & President, Directoropen-market sale8,362$63.62$532K10,884Aug 12, 2026
Aug 7, 2026Long Darren MarcVice Presidentoption exercise2,500$0.00—6,490Aug 11, 2026
Aug 7, 2026Long Darren MarcVice Presidenttax withholding734$66.89$49K5,756Aug 11, 2026
Aug 7, 2026Moschner MatthewCEO & President, Directoroption exercise4,999$0.00—21,464Aug 11, 2026
Aug 7, 2026Moschner MatthewCEO & President, Directortax withholding2,218$66.89$148K19,246Aug 11, 2026
May 27, 2026Long Darren MarcVice Presidentoption exercise4,500$56.44$254K10,069May 28, 2026
May 27, 2026Long Darren MarcVice Presidentopen-market sale4,500$66.32$298K5,569May 28, 2026
May 27, 2026Long Darren MarcVice Presidentoption exercise8,675$51.49$447K14,244May 28, 2026
May 27, 2026Long Darren MarcVice Presidentopen-market sale8,675$66.32$575K5,569May 28, 2026
May 27, 2026Long Darren MarcVice Presidentoption exercise5,498$49.12$270K11,067May 28, 2026
May 27, 2026Long Darren MarcVice Presidentopen-market sale5,498$66.32$365K5,569May 28, 2026
May 27, 2026Long Darren MarcVice Presidentopen-market sale1,579$66.52$105K3,990May 28, 2026
May 12, 2026Macdonald Laura AnnVP and PAOoption exercise6,100$47.21$288K11,358May 12, 2026
May 12, 2026Macdonald Laura AnnVP and PAOopen-market sale6,100$65.56$400K5,258May 12, 2026
May 12, 2026Macdonald Laura AnnVP and PAOoption exercise10,000$48.28$483K15,258May 12, 2026
May 12, 2026Macdonald Laura AnnVP and PAOopen-market sale10,000$65.56$656K5,258May 12, 2026
May 12, 2026Macdonald Laura AnnVP and PAOoption exercise25,500$50.94$1M30,758May 12, 2026

Full insider history for Cognex Corp, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held CGNX in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CGNX by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$91M1M0.14%trimmed −28.1%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
COGNEX CORP, CIK 851205 on EDGAR
Extract generated
November 8, 2026
Withheld
9 line-years whose four quarters do not sum to the filed year: revenue FY2014, gross profit FY2017, net income FY2017, operating income FY2017, revenue FY2017, gross profit FY2018, net income FY2018, operating income FY2018, revenue FY2018
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/CGNX.json